- Home
- HRTX vs NEWT Comparison
HRTX vs NEWT Comparison
Compare HRTX & NEWT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HRTX
- NEWT
- Stock Information
- Founded
- HRTX 1983
- NEWT 1998
- Country
- HRTX United States
- NEWT United States
- Employees
- HRTX 122
- NEWT N/A
- Industry
- HRTX Biotechnology: Pharmaceutical Preparations
- NEWT Major Banks
- Sector
- HRTX Health Care
- NEWT Finance
- Exchange
- HRTX Nasdaq
- NEWT Nasdaq
- Market Cap
- HRTX 206.9M
- NEWT 294.8M
- IPO Year
- HRTX 1987
- NEWT N/A
- Fundamental
- Price
- HRTX $1.35
- NEWT $12.37
- Analyst Decision
- HRTX Strong Buy
- NEWT Hold
- Analyst Count
- HRTX 2
- NEWT 4
- Target Price
- HRTX $4.50
- NEWT $13.00
- AVG Volume (30 Days)
- HRTX 2.6M
- NEWT 188.9K
- Earning Date
- HRTX 08-08-2025
- NEWT 07-28-2025
- Dividend Yield
- HRTX N/A
- NEWT 6.14%
- EPS Growth
- HRTX N/A
- NEWT 21.23
- EPS
- HRTX N/A
- NEWT 2.01
- Revenue
- HRTX $149,694,000.00
- NEWT $364,004,000.00
- Revenue This Year
- HRTX $10.62
- NEWT N/A
- Revenue Next Year
- HRTX $12.99
- NEWT $12.73
- P/E Ratio
- HRTX N/A
- NEWT $6.15
- Revenue Growth
- HRTX 9.78
- NEWT 20.91
- 52 Week Low
- HRTX $1.04
- NEWT $9.12
- 52 Week High
- HRTX $2.68
- NEWT $15.49
- Technical
- Relative Strength Index (RSI)
- HRTX 36.48
- NEWT 61.20
- Support Level
- HRTX $1.33
- NEWT $12.16
- Resistance Level
- HRTX $1.43
- NEWT $12.48
- Average True Range (ATR)
- HRTX 0.07
- NEWT 0.27
- MACD
- HRTX 0.02
- NEWT 0.02
- Stochastic Oscillator
- HRTX 45.45
- NEWT 73.00
About HRTX Heron Therapeutics Inc.
Heron Therapeutics Inc is a commercial-stage biotechnology company. It is focused on improving the lives of patients by developing treatments that address some of the unmet patient needs. The company's product portfolio consists of APONVIE, SUSTOL, ZYNRELEF, and CINVANTI.
About NEWT NewtekOne Inc.
NewtekOne Inc is a financial holding company engaged in providing financial solutions to its Client Base. It is an internally managed non-diversified closed-end management investment company. It has four reportable segments Banking, Alternative Lending, Technology, NSBF, and Payments.